Cargando…
Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families
BACKGROUND: 25(OH) vitamin D levels may be low in patients with moderately or severely active inflammatory bowel diseases (IBD: Crohn’s disease and Idiopathic Ulcerative Colitis) but this is less clear in patients with mild or inactive IBD. Furthermore there is limited information of any family infl...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828424/ https://www.ncbi.nlm.nih.gov/pubmed/24206944 http://dx.doi.org/10.1186/1475-2891-12-145 |
_version_ | 1782291246846312448 |
---|---|
author | Grunbaum, Avigyle Holcroft, Christina Heilpern, Debra Gladman, Stephanie Burstein, Barry Menard, Maryse Al-Abbad, Jasim Cassoff, Jamie MacNamara, Elizabeth Gordon, Philip H Szilagyi, Andrew |
author_facet | Grunbaum, Avigyle Holcroft, Christina Heilpern, Debra Gladman, Stephanie Burstein, Barry Menard, Maryse Al-Abbad, Jasim Cassoff, Jamie MacNamara, Elizabeth Gordon, Philip H Szilagyi, Andrew |
author_sort | Grunbaum, Avigyle |
collection | PubMed |
description | BACKGROUND: 25(OH) vitamin D levels may be low in patients with moderately or severely active inflammatory bowel diseases (IBD: Crohn’s disease and Idiopathic Ulcerative Colitis) but this is less clear in patients with mild or inactive IBD. Furthermore there is limited information of any family influence on 25(OH) vitamin D levels in IBD. As a possible risk factor we hypothesize that vitamin D levels may also be low in families of IBD patients. OBJECTIVES: To evaluate 25[OH] vitamin D levels in patients with IBD in remission or with mild activity. A second objective is to evaluate whether there are relationships within IBD family units of 25[OH] vitamin D and what are the influences associated with these levels. METHODS: Participants underwent medical history, physical examination and a 114 item diet questionnaire. Serum 25[OH] vitamin D was measured, using a radioimmunoassay kit, (replete ≥ 75, insufficient 50–74, deficient < 25–50, or severely deficient < 25 nmol/L). Associations between 25[OH] vitamin D and twenty variables were evaluated using univariate regression. Multivariable analysis was also applied and intrafamilial dynamics were assessed. RESULTS: 55 patients and 48 controls with their respective families participated (N206). 25[OH] vitamin D levels between patients and controls were similar (71.2 ± 32.8 vs. 68.3 ±26.2 nmol/L). Vitamin D supplements significantly increased intake but correlation with serum 25[OH] vitamin D was significant only during non sunny months among patients. Within family units, patients’ families had mean replete levels (82.3 ± 34.2 nmol/L) and a modest correlation emerged during sunny months between patients and family (r(2) =0.209 p = 0.032). These relationships were less robust and non significant in controls and their families. CONCLUSIONS: In patients with mild or inactive IBD 25[OH] vitamin D levels are less than ideal but are similar to controls. Taken together collectively, the results of this study suggest that patient family dynamics may be different in IBD units from that in control family units. However contrary to the hypothesis, intra familial vitamin D dynamics do not pose additional risks for development of IBD. |
format | Online Article Text |
id | pubmed-3828424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38284242013-11-16 Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families Grunbaum, Avigyle Holcroft, Christina Heilpern, Debra Gladman, Stephanie Burstein, Barry Menard, Maryse Al-Abbad, Jasim Cassoff, Jamie MacNamara, Elizabeth Gordon, Philip H Szilagyi, Andrew Nutr J Research BACKGROUND: 25(OH) vitamin D levels may be low in patients with moderately or severely active inflammatory bowel diseases (IBD: Crohn’s disease and Idiopathic Ulcerative Colitis) but this is less clear in patients with mild or inactive IBD. Furthermore there is limited information of any family influence on 25(OH) vitamin D levels in IBD. As a possible risk factor we hypothesize that vitamin D levels may also be low in families of IBD patients. OBJECTIVES: To evaluate 25[OH] vitamin D levels in patients with IBD in remission or with mild activity. A second objective is to evaluate whether there are relationships within IBD family units of 25[OH] vitamin D and what are the influences associated with these levels. METHODS: Participants underwent medical history, physical examination and a 114 item diet questionnaire. Serum 25[OH] vitamin D was measured, using a radioimmunoassay kit, (replete ≥ 75, insufficient 50–74, deficient < 25–50, or severely deficient < 25 nmol/L). Associations between 25[OH] vitamin D and twenty variables were evaluated using univariate regression. Multivariable analysis was also applied and intrafamilial dynamics were assessed. RESULTS: 55 patients and 48 controls with their respective families participated (N206). 25[OH] vitamin D levels between patients and controls were similar (71.2 ± 32.8 vs. 68.3 ±26.2 nmol/L). Vitamin D supplements significantly increased intake but correlation with serum 25[OH] vitamin D was significant only during non sunny months among patients. Within family units, patients’ families had mean replete levels (82.3 ± 34.2 nmol/L) and a modest correlation emerged during sunny months between patients and family (r(2) =0.209 p = 0.032). These relationships were less robust and non significant in controls and their families. CONCLUSIONS: In patients with mild or inactive IBD 25[OH] vitamin D levels are less than ideal but are similar to controls. Taken together collectively, the results of this study suggest that patient family dynamics may be different in IBD units from that in control family units. However contrary to the hypothesis, intra familial vitamin D dynamics do not pose additional risks for development of IBD. BioMed Central 2013-11-09 /pmc/articles/PMC3828424/ /pubmed/24206944 http://dx.doi.org/10.1186/1475-2891-12-145 Text en Copyright © 2013 Grunbaum et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Grunbaum, Avigyle Holcroft, Christina Heilpern, Debra Gladman, Stephanie Burstein, Barry Menard, Maryse Al-Abbad, Jasim Cassoff, Jamie MacNamara, Elizabeth Gordon, Philip H Szilagyi, Andrew Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families |
title | Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families |
title_full | Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families |
title_fullStr | Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families |
title_full_unstemmed | Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families |
title_short | Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families |
title_sort | dynamics of vitamin d in patients with mild or inactive inflammatory bowel disease and their families |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828424/ https://www.ncbi.nlm.nih.gov/pubmed/24206944 http://dx.doi.org/10.1186/1475-2891-12-145 |
work_keys_str_mv | AT grunbaumavigyle dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT holcroftchristina dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT heilperndebra dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT gladmanstephanie dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT bursteinbarry dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT menardmaryse dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT alabbadjasim dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT cassoffjamie dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT macnamaraelizabeth dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT gordonphiliph dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies AT szilagyiandrew dynamicsofvitamindinpatientswithmildorinactiveinflammatoryboweldiseaseandtheirfamilies |